Pruritic Papular Eruption of HIV (PPE-HIV)

rgb(51,102,75)
Last updated June 10, 2014
Case Authors: 
Kate Khorsand, BS
University of Washington School of Medicine
Roy Colven, MD
Dermatology Section Head, Harborview Medical Center 
Associate Professor of Dermatology
University of Washington School of Medicine
Learning Objectives: 
  1. Understand the relationship of PPE-HIV to CD4 count in HIV-infected patients.
  2. Describe the treatment approach for PPE in HIV-infected patients.

Display Group

References
  1. Eisman S. Pruritic papular eruption in HIV. Dermatol Clin. 2006;24:449-57, vi.
  2. Lakshmi SJ, Rao GR, Rao KA, Prasad PG, Kumar YH. Pruritic papular eruptions of HIV: a clinicopathologic and therapeutic study. Indian J Dermatol Venereol Leprol. 2008;74:501-3.
  3. Resneck JS Jr, Van Beek M, Furmanski L, et al. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA. 2004;292:2614-21.
  4. Colebunders R, Mann JM, Francis H, et al. Generalized papular pruritic eruption in African patients with human immunodeficiency virus infection. AIDS. 1987;1:117-21.
  5. Boonchai W, Laohasrisakul R, Manonukul J, Kulthanan K. Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression. Int J Dermatol. 1999;38:348-50.
  6. Ramos H, Pagliari C, Takakura CF, Sotto MN, Duarte MI. Pruritic papular eruption associated with HIV-etiopathogenesis evaluated by clinical, immunohistochemical, and ultrastructural analysis. J Dermatol. 2005;32:549-56.
  7. Hevia O, Jimenez-Acosta F, Ceballos PI, Gould EW, Penneys NS. Pruritic papular eruption of the acquired immunodeficiency syndrome: a clinicopathologic study. J Am Acad Dermatol. 1991;24:231-5.
  8. Afonso JP, Tomimori J, Michalany NS, Nonogaki S, Porro AM. Pruritic papular eruption and eosinophilic folliculitis associated with human immunodeficiency virus (HIV) infection: a histopathological and immunohistochemical comparative study. J Am Acad Dermatol. 2012;67:269-75.
  9. Navarini AA, Stoeckle M, Navarini S, et al. Antihistamines are superior to topical steroids in managing human immunodeficiency virus (HIV)-associated papular pruritic eruption. Int J Dermatol. 2010;49:83-6.
  10. Pardo RJ, Bogaert MA, Penneys NS, Byrne GE Jr, Ruiz P. UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndrome. J Am Acad Dermatol. 1992;26:423-8.
  11. Meola T, Soter NA, Ostreicher R, Sanchez M, Moy JA. The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol. 1993;29:216-20.
  12. Berman B, Flores F, Burke G 3rd. Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons. J Am Acad Dermatol. 1998;38:955-9.
  13. Castelnuovo B, Byakwaga H, Menten J, Schaefer P, Kamya M, Colebunders R. Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome? AIDS. 2008;22:269-73.